nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—ABCG2—Tamoxifen—pancreatic cancer	0.0595	0.0909	CbGbCtD
Venlafaxine—ABCG2—Erlotinib—pancreatic cancer	0.0506	0.0773	CbGbCtD
Venlafaxine—ABCG2—Irinotecan—pancreatic cancer	0.0457	0.0698	CbGbCtD
Venlafaxine—ABCG2—Fluorouracil—pancreatic cancer	0.0438	0.067	CbGbCtD
Venlafaxine—CYP2B6—Tamoxifen—pancreatic cancer	0.0418	0.0639	CbGbCtD
Venlafaxine—ABCG2—Docetaxel—pancreatic cancer	0.0335	0.0511	CbGbCtD
Venlafaxine—ABCG2—Sunitinib—pancreatic cancer	0.0333	0.0509	CbGbCtD
Venlafaxine—CYP2B6—Irinotecan—pancreatic cancer	0.0321	0.0491	CbGbCtD
Venlafaxine—CYP2C19—Tamoxifen—pancreatic cancer	0.0266	0.0406	CbGbCtD
Venlafaxine—ABCG2—Doxorubicin—pancreatic cancer	0.0249	0.0381	CbGbCtD
Venlafaxine—CYP2C9—Tamoxifen—pancreatic cancer	0.0221	0.0338	CbGbCtD
Venlafaxine—ABCB1—Tamoxifen—pancreatic cancer	0.0214	0.0328	CbGbCtD
Venlafaxine—CYP2D6—Tamoxifen—pancreatic cancer	0.0202	0.0309	CbGbCtD
Venlafaxine—ABCB1—Gemcitabine—pancreatic cancer	0.0185	0.0282	CbGbCtD
Venlafaxine—ABCB1—Erlotinib—pancreatic cancer	0.0182	0.0279	CbGbCtD
Venlafaxine—CYP2B6—Doxorubicin—pancreatic cancer	0.0175	0.0268	CbGbCtD
Venlafaxine—CYP2D6—Erlotinib—pancreatic cancer	0.0172	0.0262	CbGbCtD
Venlafaxine—ABCB1—Irinotecan—pancreatic cancer	0.0165	0.0252	CbGbCtD
Venlafaxine—CYP2C9—Fluorouracil—pancreatic cancer	0.0163	0.0249	CbGbCtD
Venlafaxine—CYP3A4—Tamoxifen—pancreatic cancer	0.0128	0.0196	CbGbCtD
Venlafaxine—ABCB1—Docetaxel—pancreatic cancer	0.0121	0.0184	CbGbCtD
Venlafaxine—ABCB1—Sunitinib—pancreatic cancer	0.012	0.0184	CbGbCtD
Venlafaxine—CYP3A4—Erlotinib—pancreatic cancer	0.0109	0.0167	CbGbCtD
Venlafaxine—CYP3A4—Irinotecan—pancreatic cancer	0.00986	0.0151	CbGbCtD
Venlafaxine—ABCB1—Doxorubicin—pancreatic cancer	0.00899	0.0137	CbGbCtD
Venlafaxine—CYP2D6—Doxorubicin—pancreatic cancer	0.00847	0.0129	CbGbCtD
Venlafaxine—CYP3A4—Docetaxel—pancreatic cancer	0.00723	0.011	CbGbCtD
Venlafaxine—CYP3A4—Sunitinib—pancreatic cancer	0.0072	0.011	CbGbCtD
Venlafaxine—CYP3A4—Doxorubicin—pancreatic cancer	0.00539	0.00823	CbGbCtD
Venlafaxine—Convulsion—Docetaxel—pancreatic cancer	8.06e-05	0.000293	CcSEcCtD
Venlafaxine—Hypertension—Docetaxel—pancreatic cancer	8.04e-05	0.000292	CcSEcCtD
Venlafaxine—Bronchitis—Doxorubicin—pancreatic cancer	8.02e-05	0.000292	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	7.96e-05	0.00029	CcSEcCtD
Venlafaxine—Arthralgia—Docetaxel—pancreatic cancer	7.92e-05	0.000288	CcSEcCtD
Venlafaxine—Myalgia—Docetaxel—pancreatic cancer	7.92e-05	0.000288	CcSEcCtD
Venlafaxine—Chest pain—Docetaxel—pancreatic cancer	7.92e-05	0.000288	CcSEcCtD
Venlafaxine—Nausea—Sunitinib—pancreatic cancer	7.92e-05	0.000288	CcSEcCtD
Venlafaxine—Pancytopenia—Doxorubicin—pancreatic cancer	7.92e-05	0.000288	CcSEcCtD
Venlafaxine—Renal failure—Epirubicin—pancreatic cancer	7.9e-05	0.000287	CcSEcCtD
Venlafaxine—Asthenia—Irinotecan—pancreatic cancer	7.88e-05	0.000287	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Epirubicin—pancreatic cancer	7.87e-05	0.000286	CcSEcCtD
Venlafaxine—Stomatitis—Epirubicin—pancreatic cancer	7.83e-05	0.000285	CcSEcCtD
Venlafaxine—Jaundice—Epirubicin—pancreatic cancer	7.83e-05	0.000285	CcSEcCtD
Venlafaxine—Conjunctivitis—Epirubicin—pancreatic cancer	7.81e-05	0.000284	CcSEcCtD
Venlafaxine—Dysuria—Doxorubicin—pancreatic cancer	7.8e-05	0.000284	CcSEcCtD
Venlafaxine—Neutropenia—Doxorubicin—pancreatic cancer	7.8e-05	0.000284	CcSEcCtD
Venlafaxine—Hypersensitivity—Fluorouracil—pancreatic cancer	7.75e-05	0.000282	CcSEcCtD
Venlafaxine—Dry mouth—Docetaxel—pancreatic cancer	7.75e-05	0.000282	CcSEcCtD
Venlafaxine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	7.75e-05	0.000282	CcSEcCtD
Venlafaxine—Sweating—Epirubicin—pancreatic cancer	7.7e-05	0.00028	CcSEcCtD
Venlafaxine—Pollakiuria—Doxorubicin—pancreatic cancer	7.7e-05	0.00028	CcSEcCtD
Venlafaxine—Asthenia—Gemcitabine—pancreatic cancer	7.68e-05	0.000279	CcSEcCtD
Venlafaxine—Haematuria—Epirubicin—pancreatic cancer	7.66e-05	0.000279	CcSEcCtD
Venlafaxine—Confusional state—Docetaxel—pancreatic cancer	7.66e-05	0.000279	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	7.61e-05	0.000277	CcSEcCtD
Venlafaxine—Oedema—Docetaxel—pancreatic cancer	7.6e-05	0.000276	CcSEcCtD
Venlafaxine—Anaphylactic shock—Docetaxel—pancreatic cancer	7.6e-05	0.000276	CcSEcCtD
Venlafaxine—Weight increased—Doxorubicin—pancreatic cancer	7.59e-05	0.000276	CcSEcCtD
Venlafaxine—Epistaxis—Epirubicin—pancreatic cancer	7.58e-05	0.000276	CcSEcCtD
Venlafaxine—Pruritus—Gemcitabine—pancreatic cancer	7.57e-05	0.000275	CcSEcCtD
Venlafaxine—Infection—Docetaxel—pancreatic cancer	7.55e-05	0.000274	CcSEcCtD
Venlafaxine—Weight decreased—Doxorubicin—pancreatic cancer	7.54e-05	0.000274	CcSEcCtD
Venlafaxine—Sinusitis—Epirubicin—pancreatic cancer	7.54e-05	0.000274	CcSEcCtD
Venlafaxine—Hyperglycaemia—Doxorubicin—pancreatic cancer	7.52e-05	0.000274	CcSEcCtD
Venlafaxine—Diarrhoea—Irinotecan—pancreatic cancer	7.52e-05	0.000273	CcSEcCtD
Venlafaxine—Agranulocytosis—Epirubicin—pancreatic cancer	7.5e-05	0.000273	CcSEcCtD
Venlafaxine—Pneumonia—Doxorubicin—pancreatic cancer	7.48e-05	0.000272	CcSEcCtD
Venlafaxine—Shock—Docetaxel—pancreatic cancer	7.47e-05	0.000272	CcSEcCtD
Venlafaxine—Pruritus—Fluorouracil—pancreatic cancer	7.45e-05	0.000271	CcSEcCtD
Venlafaxine—Thrombocytopenia—Docetaxel—pancreatic cancer	7.44e-05	0.00027	CcSEcCtD
Venlafaxine—Tachycardia—Docetaxel—pancreatic cancer	7.41e-05	0.00027	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	7.37e-05	0.000268	CcSEcCtD
Venlafaxine—Bradycardia—Epirubicin—pancreatic cancer	7.34e-05	0.000267	CcSEcCtD
Venlafaxine—Diarrhoea—Gemcitabine—pancreatic cancer	7.32e-05	0.000266	CcSEcCtD
Venlafaxine—Renal failure—Doxorubicin—pancreatic cancer	7.31e-05	0.000266	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	7.29e-05	0.000265	CcSEcCtD
Venlafaxine—Dizziness—Irinotecan—pancreatic cancer	7.27e-05	0.000264	CcSEcCtD
Venlafaxine—Haemoglobin—Epirubicin—pancreatic cancer	7.25e-05	0.000264	CcSEcCtD
Venlafaxine—Stomatitis—Doxorubicin—pancreatic cancer	7.24e-05	0.000264	CcSEcCtD
Venlafaxine—Jaundice—Doxorubicin—pancreatic cancer	7.24e-05	0.000264	CcSEcCtD
Venlafaxine—Anorexia—Docetaxel—pancreatic cancer	7.24e-05	0.000263	CcSEcCtD
Venlafaxine—Rhinitis—Epirubicin—pancreatic cancer	7.23e-05	0.000263	CcSEcCtD
Venlafaxine—Conjunctivitis—Doxorubicin—pancreatic cancer	7.22e-05	0.000263	CcSEcCtD
Venlafaxine—Haemorrhage—Epirubicin—pancreatic cancer	7.21e-05	0.000262	CcSEcCtD
Venlafaxine—Hepatitis—Epirubicin—pancreatic cancer	7.21e-05	0.000262	CcSEcCtD
Venlafaxine—Diarrhoea—Fluorouracil—pancreatic cancer	7.2e-05	0.000262	CcSEcCtD
Venlafaxine—Hypoaesthesia—Epirubicin—pancreatic cancer	7.18e-05	0.000261	CcSEcCtD
Venlafaxine—Pharyngitis—Epirubicin—pancreatic cancer	7.16e-05	0.00026	CcSEcCtD
Venlafaxine—Sweating—Doxorubicin—pancreatic cancer	7.13e-05	0.000259	CcSEcCtD
Venlafaxine—Hypotension—Docetaxel—pancreatic cancer	7.1e-05	0.000258	CcSEcCtD
Venlafaxine—Haematuria—Doxorubicin—pancreatic cancer	7.09e-05	0.000258	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	7.05e-05	0.000998	CbGpPWpGaD
Venlafaxine—Epistaxis—Doxorubicin—pancreatic cancer	7.01e-05	0.000255	CcSEcCtD
Venlafaxine—Vomiting—Irinotecan—pancreatic cancer	6.99e-05	0.000254	CcSEcCtD
Venlafaxine—Sinusitis—Doxorubicin—pancreatic cancer	6.97e-05	0.000254	CcSEcCtD
Venlafaxine—Dizziness—Fluorouracil—pancreatic cancer	6.96e-05	0.000253	CcSEcCtD
Venlafaxine—Visual impairment—Epirubicin—pancreatic cancer	6.95e-05	0.000253	CcSEcCtD
Venlafaxine—Agranulocytosis—Doxorubicin—pancreatic cancer	6.94e-05	0.000252	CcSEcCtD
Venlafaxine—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	6.93e-05	0.000981	CbGpPWpGaD
Venlafaxine—Rash—Irinotecan—pancreatic cancer	6.93e-05	0.000252	CcSEcCtD
Venlafaxine—Dermatitis—Irinotecan—pancreatic cancer	6.92e-05	0.000252	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	6.92e-05	0.000252	CcSEcCtD
Venlafaxine—Headache—Irinotecan—pancreatic cancer	6.88e-05	0.00025	CcSEcCtD
Venlafaxine—Insomnia—Docetaxel—pancreatic cancer	6.87e-05	0.00025	CcSEcCtD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.84e-05	0.000968	CbGpPWpGaD
Venlafaxine—Paraesthesia—Docetaxel—pancreatic cancer	6.82e-05	0.000248	CcSEcCtD
Venlafaxine—Erythema multiforme—Epirubicin—pancreatic cancer	6.82e-05	0.000248	CcSEcCtD
Venlafaxine—Vomiting—Gemcitabine—pancreatic cancer	6.81e-05	0.000248	CcSEcCtD
Venlafaxine—Bradycardia—Doxorubicin—pancreatic cancer	6.79e-05	0.000247	CcSEcCtD
Venlafaxine—Dyspnoea—Docetaxel—pancreatic cancer	6.77e-05	0.000246	CcSEcCtD
Venlafaxine—Somnolence—Docetaxel—pancreatic cancer	6.75e-05	0.000246	CcSEcCtD
Venlafaxine—Rash—Gemcitabine—pancreatic cancer	6.75e-05	0.000245	CcSEcCtD
Venlafaxine—Dermatitis—Gemcitabine—pancreatic cancer	6.74e-05	0.000245	CcSEcCtD
Venlafaxine—Tinnitus—Epirubicin—pancreatic cancer	6.72e-05	0.000245	CcSEcCtD
Venlafaxine—Haemoglobin—Doxorubicin—pancreatic cancer	6.71e-05	0.000244	CcSEcCtD
Venlafaxine—Headache—Gemcitabine—pancreatic cancer	6.71e-05	0.000244	CcSEcCtD
Venlafaxine—Flushing—Epirubicin—pancreatic cancer	6.69e-05	0.000243	CcSEcCtD
Venlafaxine—Cardiac disorder—Epirubicin—pancreatic cancer	6.69e-05	0.000243	CcSEcCtD
Venlafaxine—Vomiting—Fluorouracil—pancreatic cancer	6.69e-05	0.000243	CcSEcCtD
Venlafaxine—Rhinitis—Doxorubicin—pancreatic cancer	6.69e-05	0.000243	CcSEcCtD
Venlafaxine—Dyspepsia—Docetaxel—pancreatic cancer	6.69e-05	0.000243	CcSEcCtD
Venlafaxine—Haemorrhage—Doxorubicin—pancreatic cancer	6.67e-05	0.000243	CcSEcCtD
Venlafaxine—Hepatitis—Doxorubicin—pancreatic cancer	6.67e-05	0.000243	CcSEcCtD
Venlafaxine—Hypoaesthesia—Doxorubicin—pancreatic cancer	6.64e-05	0.000241	CcSEcCtD
Venlafaxine—Rash—Fluorouracil—pancreatic cancer	6.64e-05	0.000241	CcSEcCtD
Venlafaxine—Dermatitis—Fluorouracil—pancreatic cancer	6.63e-05	0.000241	CcSEcCtD
Venlafaxine—Pharyngitis—Doxorubicin—pancreatic cancer	6.62e-05	0.000241	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—SST—pancreatic cancer	6.62e-05	0.000937	CbGpPWpGaD
Venlafaxine—Decreased appetite—Docetaxel—pancreatic cancer	6.6e-05	0.00024	CcSEcCtD
Venlafaxine—Headache—Fluorouracil—pancreatic cancer	6.59e-05	0.00024	CcSEcCtD
Venlafaxine—Fatigue—Docetaxel—pancreatic cancer	6.55e-05	0.000238	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—PIK3CG—pancreatic cancer	6.53e-05	0.000924	CbGpPWpGaD
Venlafaxine—Nausea—Irinotecan—pancreatic cancer	6.53e-05	0.000237	CcSEcCtD
Venlafaxine—Pain—Docetaxel—pancreatic cancer	6.5e-05	0.000236	CcSEcCtD
Venlafaxine—Constipation—Docetaxel—pancreatic cancer	6.5e-05	0.000236	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—JAG1—pancreatic cancer	6.48e-05	0.000917	CbGpPWpGaD
Venlafaxine—Chills—Epirubicin—pancreatic cancer	6.47e-05	0.000235	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—NOTCH3—pancreatic cancer	6.45e-05	0.000913	CbGpPWpGaD
Venlafaxine—Arrhythmia—Epirubicin—pancreatic cancer	6.44e-05	0.000234	CcSEcCtD
Venlafaxine—Visual impairment—Doxorubicin—pancreatic cancer	6.43e-05	0.000234	CcSEcCtD
Venlafaxine—Alopecia—Epirubicin—pancreatic cancer	6.37e-05	0.000232	CcSEcCtD
Venlafaxine—Nausea—Gemcitabine—pancreatic cancer	6.36e-05	0.000231	CcSEcCtD
Venlafaxine—Erythema multiforme—Doxorubicin—pancreatic cancer	6.31e-05	0.000229	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	6.29e-05	0.000891	CbGpPWpGaD
Venlafaxine—Erythema—Epirubicin—pancreatic cancer	6.28e-05	0.000228	CcSEcCtD
Venlafaxine—Feeling abnormal—Docetaxel—pancreatic cancer	6.26e-05	0.000228	CcSEcCtD
Venlafaxine—Nausea—Fluorouracil—pancreatic cancer	6.25e-05	0.000227	CcSEcCtD
Venlafaxine—Tinnitus—Doxorubicin—pancreatic cancer	6.22e-05	0.000226	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Docetaxel—pancreatic cancer	6.21e-05	0.000226	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	6.21e-05	0.000879	CbGpPWpGaD
Venlafaxine—Cardiac disorder—Doxorubicin—pancreatic cancer	6.19e-05	0.000225	CcSEcCtD
Venlafaxine—Flushing—Doxorubicin—pancreatic cancer	6.19e-05	0.000225	CcSEcCtD
Venlafaxine—Flatulence—Epirubicin—pancreatic cancer	6.19e-05	0.000225	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	6.18e-05	0.000875	CbGpPWpGaD
Venlafaxine—Tension—Epirubicin—pancreatic cancer	6.16e-05	0.000224	CcSEcCtD
Venlafaxine—Dysgeusia—Epirubicin—pancreatic cancer	6.15e-05	0.000224	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—CNR1—pancreatic cancer	6.11e-05	0.000865	CbGpPWpGaD
Venlafaxine—Nervousness—Epirubicin—pancreatic cancer	6.1e-05	0.000222	CcSEcCtD
Venlafaxine—Back pain—Epirubicin—pancreatic cancer	6.07e-05	0.000221	CcSEcCtD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.06e-05	0.000858	CbGpPWpGaD
Venlafaxine—Muscle spasms—Epirubicin—pancreatic cancer	6.04e-05	0.00022	CcSEcCtD
Venlafaxine—SLC6A4—NRF2 pathway—TGFB1—pancreatic cancer	6.01e-05	0.000851	CbGpPWpGaD
Venlafaxine—Body temperature increased—Docetaxel—pancreatic cancer	6e-05	0.000218	CcSEcCtD
Venlafaxine—Abdominal pain—Docetaxel—pancreatic cancer	6e-05	0.000218	CcSEcCtD
Venlafaxine—Chills—Doxorubicin—pancreatic cancer	5.99e-05	0.000218	CcSEcCtD
Venlafaxine—Arrhythmia—Doxorubicin—pancreatic cancer	5.96e-05	0.000217	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—PIK3CG—pancreatic cancer	5.93e-05	0.00084	CbGpPWpGaD
Venlafaxine—Vision blurred—Epirubicin—pancreatic cancer	5.92e-05	0.000215	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—GCG—pancreatic cancer	5.9e-05	0.000835	CbGpPWpGaD
Venlafaxine—Alopecia—Doxorubicin—pancreatic cancer	5.9e-05	0.000214	CcSEcCtD
Venlafaxine—Ill-defined disorder—Epirubicin—pancreatic cancer	5.82e-05	0.000212	CcSEcCtD
Venlafaxine—Erythema—Doxorubicin—pancreatic cancer	5.81e-05	0.000211	CcSEcCtD
Venlafaxine—Anaemia—Epirubicin—pancreatic cancer	5.8e-05	0.000211	CcSEcCtD
Venlafaxine—Agitation—Epirubicin—pancreatic cancer	5.77e-05	0.00021	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.74e-05	0.000813	CbGpPWpGaD
Venlafaxine—Flatulence—Doxorubicin—pancreatic cancer	5.72e-05	0.000208	CcSEcCtD
Venlafaxine—Tension—Doxorubicin—pancreatic cancer	5.7e-05	0.000207	CcSEcCtD
Venlafaxine—Dysgeusia—Doxorubicin—pancreatic cancer	5.69e-05	0.000207	CcSEcCtD
Venlafaxine—Malaise—Epirubicin—pancreatic cancer	5.66e-05	0.000206	CcSEcCtD
Venlafaxine—Nervousness—Doxorubicin—pancreatic cancer	5.64e-05	0.000205	CcSEcCtD
Venlafaxine—Vertigo—Epirubicin—pancreatic cancer	5.64e-05	0.000205	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—AGTR1—pancreatic cancer	5.63e-05	0.000797	CbGpPWpGaD
Venlafaxine—Syncope—Epirubicin—pancreatic cancer	5.63e-05	0.000205	CcSEcCtD
Venlafaxine—Leukopenia—Epirubicin—pancreatic cancer	5.62e-05	0.000204	CcSEcCtD
Venlafaxine—Back pain—Doxorubicin—pancreatic cancer	5.62e-05	0.000204	CcSEcCtD
Venlafaxine—SLC6A4—Circadian rythm related genes—PTEN—pancreatic cancer	5.61e-05	0.000794	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Docetaxel—pancreatic cancer	5.6e-05	0.000204	CcSEcCtD
Venlafaxine—Muscle spasms—Doxorubicin—pancreatic cancer	5.58e-05	0.000203	CcSEcCtD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.57e-05	0.000789	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—STK11—pancreatic cancer	5.55e-05	0.000785	CbGpPWpGaD
Venlafaxine—Palpitations—Epirubicin—pancreatic cancer	5.55e-05	0.000202	CcSEcCtD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	5.52e-05	0.000782	CbGpPWpGaD
Venlafaxine—Loss of consciousness—Epirubicin—pancreatic cancer	5.52e-05	0.000201	CcSEcCtD
Venlafaxine—Cough—Epirubicin—pancreatic cancer	5.48e-05	0.000199	CcSEcCtD
Venlafaxine—Vision blurred—Doxorubicin—pancreatic cancer	5.47e-05	0.000199	CcSEcCtD
Venlafaxine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	5.46e-05	0.000773	CbGpPWpGaD
Venlafaxine—Asthenia—Docetaxel—pancreatic cancer	5.45e-05	0.000198	CcSEcCtD
Venlafaxine—Convulsion—Epirubicin—pancreatic cancer	5.44e-05	0.000198	CcSEcCtD
Venlafaxine—Hypertension—Epirubicin—pancreatic cancer	5.42e-05	0.000197	CcSEcCtD
Venlafaxine—Ill-defined disorder—Doxorubicin—pancreatic cancer	5.39e-05	0.000196	CcSEcCtD
Venlafaxine—Pruritus—Docetaxel—pancreatic cancer	5.37e-05	0.000195	CcSEcCtD
Venlafaxine—Anaemia—Doxorubicin—pancreatic cancer	5.37e-05	0.000195	CcSEcCtD
Venlafaxine—Myalgia—Epirubicin—pancreatic cancer	5.34e-05	0.000194	CcSEcCtD
Venlafaxine—Arthralgia—Epirubicin—pancreatic cancer	5.34e-05	0.000194	CcSEcCtD
Venlafaxine—Chest pain—Epirubicin—pancreatic cancer	5.34e-05	0.000194	CcSEcCtD
Venlafaxine—Agitation—Doxorubicin—pancreatic cancer	5.34e-05	0.000194	CcSEcCtD
Venlafaxine—Anxiety—Epirubicin—pancreatic cancer	5.33e-05	0.000194	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—pancreatic cancer	5.32e-05	0.000753	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	5.3e-05	0.00075	CbGpPWpGaD
Venlafaxine—Discomfort—Epirubicin—pancreatic cancer	5.28e-05	0.000192	CcSEcCtD
Venlafaxine—Malaise—Doxorubicin—pancreatic cancer	5.24e-05	0.000191	CcSEcCtD
Venlafaxine—Dry mouth—Epirubicin—pancreatic cancer	5.23e-05	0.00019	CcSEcCtD
Venlafaxine—Vertigo—Doxorubicin—pancreatic cancer	5.22e-05	0.00019	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—PIK3CD—pancreatic cancer	5.21e-05	0.000738	CbGpPWpGaD
Venlafaxine—Syncope—Doxorubicin—pancreatic cancer	5.21e-05	0.000189	CcSEcCtD
Venlafaxine—Leukopenia—Doxorubicin—pancreatic cancer	5.2e-05	0.000189	CcSEcCtD
Venlafaxine—Diarrhoea—Docetaxel—pancreatic cancer	5.2e-05	0.000189	CcSEcCtD
Venlafaxine—SLC6A2—NRF2 pathway—TGFB1—pancreatic cancer	5.17e-05	0.000731	CbGpPWpGaD
Venlafaxine—Confusional state—Epirubicin—pancreatic cancer	5.17e-05	0.000188	CcSEcCtD
Venlafaxine—Palpitations—Doxorubicin—pancreatic cancer	5.13e-05	0.000187	CcSEcCtD
Venlafaxine—Oedema—Epirubicin—pancreatic cancer	5.12e-05	0.000186	CcSEcCtD
Venlafaxine—Anaphylactic shock—Epirubicin—pancreatic cancer	5.12e-05	0.000186	CcSEcCtD
Venlafaxine—Loss of consciousness—Doxorubicin—pancreatic cancer	5.11e-05	0.000186	CcSEcCtD
Venlafaxine—Infection—Epirubicin—pancreatic cancer	5.09e-05	0.000185	CcSEcCtD
Venlafaxine—Cough—Doxorubicin—pancreatic cancer	5.07e-05	0.000184	CcSEcCtD
Venlafaxine—Shock—Epirubicin—pancreatic cancer	5.04e-05	0.000183	CcSEcCtD
Venlafaxine—Convulsion—Doxorubicin—pancreatic cancer	5.03e-05	0.000183	CcSEcCtD
Venlafaxine—Dizziness—Docetaxel—pancreatic cancer	5.02e-05	0.000183	CcSEcCtD
Venlafaxine—Thrombocytopenia—Epirubicin—pancreatic cancer	5.02e-05	0.000182	CcSEcCtD
Venlafaxine—Hypertension—Doxorubicin—pancreatic cancer	5.01e-05	0.000182	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—PIK3CB—pancreatic cancer	5e-05	0.000708	CbGpPWpGaD
Venlafaxine—Tachycardia—Epirubicin—pancreatic cancer	5e-05	0.000182	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	4.99e-05	0.000706	CbGpPWpGaD
Venlafaxine—Hyperhidrosis—Epirubicin—pancreatic cancer	4.95e-05	0.00018	CcSEcCtD
Venlafaxine—Chest pain—Doxorubicin—pancreatic cancer	4.95e-05	0.00018	CcSEcCtD
Venlafaxine—Arthralgia—Doxorubicin—pancreatic cancer	4.95e-05	0.00018	CcSEcCtD
Venlafaxine—Myalgia—Doxorubicin—pancreatic cancer	4.95e-05	0.00018	CcSEcCtD
Venlafaxine—Anxiety—Doxorubicin—pancreatic cancer	4.93e-05	0.000179	CcSEcCtD
Venlafaxine—Discomfort—Doxorubicin—pancreatic cancer	4.89e-05	0.000178	CcSEcCtD
Venlafaxine—Anorexia—Epirubicin—pancreatic cancer	4.88e-05	0.000178	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—SMAD4—pancreatic cancer	4.86e-05	0.000688	CbGpPWpGaD
Venlafaxine—Dry mouth—Doxorubicin—pancreatic cancer	4.84e-05	0.000176	CcSEcCtD
Venlafaxine—Vomiting—Docetaxel—pancreatic cancer	4.83e-05	0.000176	CcSEcCtD
Venlafaxine—NPY1R—GPCR downstream signaling—CXCL8—pancreatic cancer	4.81e-05	0.000681	CbGpPWpGaD
Venlafaxine—Rash—Docetaxel—pancreatic cancer	4.79e-05	0.000174	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	4.79e-05	0.000678	CbGpPWpGaD
Venlafaxine—Hypotension—Epirubicin—pancreatic cancer	4.79e-05	0.000174	CcSEcCtD
Venlafaxine—Dermatitis—Docetaxel—pancreatic cancer	4.78e-05	0.000174	CcSEcCtD
Venlafaxine—Confusional state—Doxorubicin—pancreatic cancer	4.78e-05	0.000174	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	4.77e-05	0.000676	CbGpPWpGaD
Venlafaxine—Headache—Docetaxel—pancreatic cancer	4.76e-05	0.000173	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—HES1—pancreatic cancer	4.75e-05	0.000672	CbGpPWpGaD
Venlafaxine—Oedema—Doxorubicin—pancreatic cancer	4.74e-05	0.000172	CcSEcCtD
Venlafaxine—Anaphylactic shock—Doxorubicin—pancreatic cancer	4.74e-05	0.000172	CcSEcCtD
Venlafaxine—Infection—Doxorubicin—pancreatic cancer	4.71e-05	0.000171	CcSEcCtD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	4.68e-05	0.000662	CbGpPWpGaD
Venlafaxine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	4.67e-05	0.00017	CcSEcCtD
Venlafaxine—Shock—Doxorubicin—pancreatic cancer	4.66e-05	0.00017	CcSEcCtD
Venlafaxine—Thrombocytopenia—Doxorubicin—pancreatic cancer	4.64e-05	0.000169	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	4.64e-05	0.000657	CbGpPWpGaD
Venlafaxine—Insomnia—Epirubicin—pancreatic cancer	4.63e-05	0.000169	CcSEcCtD
Venlafaxine—Tachycardia—Doxorubicin—pancreatic cancer	4.63e-05	0.000168	CcSEcCtD
Venlafaxine—Paraesthesia—Epirubicin—pancreatic cancer	4.6e-05	0.000167	CcSEcCtD
Venlafaxine—Hyperhidrosis—Doxorubicin—pancreatic cancer	4.58e-05	0.000167	CcSEcCtD
Venlafaxine—SLC6A3—NRF2 pathway—TGFB1—pancreatic cancer	4.58e-05	0.000648	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PRSS1—pancreatic cancer	4.58e-05	0.000648	CbGpPWpGaD
Venlafaxine—Dyspnoea—Epirubicin—pancreatic cancer	4.57e-05	0.000166	CcSEcCtD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	4.56e-05	0.000645	CbGpPWpGaD
Venlafaxine—Somnolence—Epirubicin—pancreatic cancer	4.55e-05	0.000166	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—PIK3CB—pancreatic cancer	4.54e-05	0.000643	CbGpPWpGaD
Venlafaxine—Anorexia—Doxorubicin—pancreatic cancer	4.52e-05	0.000164	CcSEcCtD
Venlafaxine—Nausea—Docetaxel—pancreatic cancer	4.51e-05	0.000164	CcSEcCtD
Venlafaxine—Dyspepsia—Epirubicin—pancreatic cancer	4.51e-05	0.000164	CcSEcCtD
Venlafaxine—Decreased appetite—Epirubicin—pancreatic cancer	4.45e-05	0.000162	CcSEcCtD
Venlafaxine—Hypotension—Doxorubicin—pancreatic cancer	4.43e-05	0.000161	CcSEcCtD
Venlafaxine—Fatigue—Epirubicin—pancreatic cancer	4.42e-05	0.000161	CcSEcCtD
Venlafaxine—Constipation—Epirubicin—pancreatic cancer	4.38e-05	0.000159	CcSEcCtD
Venlafaxine—Pain—Epirubicin—pancreatic cancer	4.38e-05	0.000159	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—CXCL8—pancreatic cancer	4.37e-05	0.000618	CbGpPWpGaD
Venlafaxine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.32e-05	0.000157	CcSEcCtD
Venlafaxine—Insomnia—Doxorubicin—pancreatic cancer	4.29e-05	0.000156	CcSEcCtD
Venlafaxine—Paraesthesia—Doxorubicin—pancreatic cancer	4.26e-05	0.000155	CcSEcCtD
Venlafaxine—Dyspnoea—Doxorubicin—pancreatic cancer	4.23e-05	0.000154	CcSEcCtD
Venlafaxine—Feeling abnormal—Epirubicin—pancreatic cancer	4.22e-05	0.000154	CcSEcCtD
Venlafaxine—Somnolence—Doxorubicin—pancreatic cancer	4.21e-05	0.000153	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.19e-05	0.000152	CcSEcCtD
Venlafaxine—Dyspepsia—Doxorubicin—pancreatic cancer	4.17e-05	0.000152	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—TERT—pancreatic cancer	4.16e-05	0.000589	CbGpPWpGaD
Venlafaxine—Decreased appetite—Doxorubicin—pancreatic cancer	4.12e-05	0.00015	CcSEcCtD
Venlafaxine—Fatigue—Doxorubicin—pancreatic cancer	4.09e-05	0.000149	CcSEcCtD
Venlafaxine—Urticaria—Epirubicin—pancreatic cancer	4.07e-05	0.000148	CcSEcCtD
Venlafaxine—Pain—Doxorubicin—pancreatic cancer	4.05e-05	0.000147	CcSEcCtD
Venlafaxine—Constipation—Doxorubicin—pancreatic cancer	4.05e-05	0.000147	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	4.05e-05	0.000574	CbGpPWpGaD
Venlafaxine—Body temperature increased—Epirubicin—pancreatic cancer	4.05e-05	0.000147	CcSEcCtD
Venlafaxine—Abdominal pain—Epirubicin—pancreatic cancer	4.05e-05	0.000147	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—HIF1A—pancreatic cancer	3.98e-05	0.000563	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ARG2—pancreatic cancer	3.97e-05	0.000562	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TSC2—pancreatic cancer	3.97e-05	0.000562	CbGpPWpGaD
Venlafaxine—Feeling abnormal—Doxorubicin—pancreatic cancer	3.91e-05	0.000142	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—APOE—pancreatic cancer	3.88e-05	0.00055	CbGpPWpGaD
Venlafaxine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	3.88e-05	0.000141	CcSEcCtD
Venlafaxine—SLC6A4—Circadian rythm related genes—TP53—pancreatic cancer	3.83e-05	0.000542	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—KDR—pancreatic cancer	3.8e-05	0.000538	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Epirubicin—pancreatic cancer	3.77e-05	0.000137	CcSEcCtD
Venlafaxine—Urticaria—Doxorubicin—pancreatic cancer	3.77e-05	0.000137	CcSEcCtD
Venlafaxine—Body temperature increased—Doxorubicin—pancreatic cancer	3.75e-05	0.000136	CcSEcCtD
Venlafaxine—Abdominal pain—Doxorubicin—pancreatic cancer	3.75e-05	0.000136	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	3.72e-05	0.000526	CbGpPWpGaD
Venlafaxine—Asthenia—Epirubicin—pancreatic cancer	3.68e-05	0.000134	CcSEcCtD
Venlafaxine—Pruritus—Epirubicin—pancreatic cancer	3.62e-05	0.000132	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—NFKBIA—pancreatic cancer	3.62e-05	0.000512	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NOTCH1—pancreatic cancer	3.58e-05	0.000507	CbGpPWpGaD
Venlafaxine—Diarrhoea—Epirubicin—pancreatic cancer	3.51e-05	0.000127	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CG—pancreatic cancer	3.5e-05	0.000496	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—NRAS—pancreatic cancer	3.5e-05	0.000496	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Doxorubicin—pancreatic cancer	3.49e-05	0.000127	CcSEcCtD
Venlafaxine—ABCB1—Allograft Rejection—TNF—pancreatic cancer	3.47e-05	0.000492	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—TYMP—pancreatic cancer	3.47e-05	0.000491	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EGF—pancreatic cancer	3.46e-05	0.00049	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	3.45e-05	0.000489	CbGpPWpGaD
Venlafaxine—Asthenia—Doxorubicin—pancreatic cancer	3.4e-05	0.000124	CcSEcCtD
Venlafaxine—Dizziness—Epirubicin—pancreatic cancer	3.39e-05	0.000123	CcSEcCtD
Venlafaxine—Pruritus—Doxorubicin—pancreatic cancer	3.35e-05	0.000122	CcSEcCtD
Venlafaxine—CYP2B6—Metabolism—PRSS1—pancreatic cancer	3.35e-05	0.000475	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	3.3e-05	0.000468	CbGpPWpGaD
Venlafaxine—Vomiting—Epirubicin—pancreatic cancer	3.26e-05	0.000118	CcSEcCtD
Venlafaxine—Diarrhoea—Doxorubicin—pancreatic cancer	3.24e-05	0.000118	CcSEcCtD
Venlafaxine—Rash—Epirubicin—pancreatic cancer	3.23e-05	0.000117	CcSEcCtD
Venlafaxine—Dermatitis—Epirubicin—pancreatic cancer	3.23e-05	0.000117	CcSEcCtD
Venlafaxine—Headache—Epirubicin—pancreatic cancer	3.21e-05	0.000117	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—EGFR—pancreatic cancer	3.19e-05	0.000452	CbGpPWpGaD
Venlafaxine—Dizziness—Doxorubicin—pancreatic cancer	3.13e-05	0.000114	CcSEcCtD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CD—pancreatic cancer	3.08e-05	0.000436	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.05e-05	0.000432	CbGpPWpGaD
Venlafaxine—Nausea—Epirubicin—pancreatic cancer	3.04e-05	0.000111	CcSEcCtD
Venlafaxine—NPY1R—Signaling by GPCR—KRAS—pancreatic cancer	3.02e-05	0.000427	CbGpPWpGaD
Venlafaxine—Vomiting—Doxorubicin—pancreatic cancer	3.01e-05	0.00011	CcSEcCtD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.01e-05	0.000426	CbGpPWpGaD
Venlafaxine—Rash—Doxorubicin—pancreatic cancer	2.99e-05	0.000109	CcSEcCtD
Venlafaxine—Dermatitis—Doxorubicin—pancreatic cancer	2.99e-05	0.000109	CcSEcCtD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	2.99e-05	0.000423	CbGpPWpGaD
Venlafaxine—Headache—Doxorubicin—pancreatic cancer	2.97e-05	0.000108	CcSEcCtD
Venlafaxine—CYP2B6—Metabolism—ARG2—pancreatic cancer	2.91e-05	0.000412	CbGpPWpGaD
Venlafaxine—Nausea—Doxorubicin—pancreatic cancer	2.82e-05	0.000102	CcSEcCtD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.8e-05	0.000397	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GLP1R—pancreatic cancer	2.79e-05	0.000396	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—PIK3CA—pancreatic cancer	2.77e-05	0.000392	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—DPYD—pancreatic cancer	2.75e-05	0.000389	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CB—pancreatic cancer	2.68e-05	0.00038	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—SLC2A2—pancreatic cancer	2.61e-05	0.000369	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CXCL8—pancreatic cancer	2.58e-05	0.000365	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—HRAS—pancreatic cancer	2.56e-05	0.000363	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—TYMP—pancreatic cancer	2.54e-05	0.00036	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	2.54e-05	0.000359	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PRSS1—pancreatic cancer	2.53e-05	0.000359	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—AKT1—pancreatic cancer	2.49e-05	0.000353	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PRSS1—pancreatic cancer	2.47e-05	0.00035	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CASP3—pancreatic cancer	2.47e-05	0.00035	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCND1—pancreatic cancer	2.4e-05	0.00034	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CTNNB1—pancreatic cancer	2.38e-05	0.000337	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.36e-05	0.000334	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MMP9—pancreatic cancer	2.33e-05	0.00033	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	2.33e-05	0.00033	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PTEN—pancreatic cancer	2.32e-05	0.000328	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PRSS1—pancreatic cancer	2.31e-05	0.000327	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.29e-05	0.000325	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.27e-05	0.000322	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—AKT1—pancreatic cancer	2.26e-05	0.00032	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.21e-05	0.000313	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ARG2—pancreatic cancer	2.2e-05	0.000311	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—SRC—pancreatic cancer	2.15e-05	0.000305	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—HRAS—pancreatic cancer	2.15e-05	0.000304	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ARG2—pancreatic cancer	2.14e-05	0.000304	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—VEGFA—pancreatic cancer	2.1e-05	0.000297	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—STAT3—pancreatic cancer	2.07e-05	0.000294	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NRAS—pancreatic cancer	2.07e-05	0.000293	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.05e-05	0.000291	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GLP1R—pancreatic cancer	2.05e-05	0.00029	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ARG2—pancreatic cancer	2.02e-05	0.000286	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CD44—pancreatic cancer	2.02e-05	0.000286	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—DPYD—pancreatic cancer	2.02e-05	0.000285	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ARG2—pancreatic cancer	2e-05	0.000284	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2e-05	0.000283	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GCG—pancreatic cancer	1.94e-05	0.000274	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MYC—pancreatic cancer	1.93e-05	0.000273	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TGFB1—pancreatic cancer	1.92e-05	0.000272	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—TYMP—pancreatic cancer	1.92e-05	0.000272	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—SLC2A2—pancreatic cancer	1.91e-05	0.000271	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EGFR—pancreatic cancer	1.89e-05	0.000267	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—TYMP—pancreatic cancer	1.87e-05	0.000265	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.84e-05	0.00026	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.84e-05	0.00026	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—STK11—pancreatic cancer	1.82e-05	0.000258	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.8e-05	0.000255	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—KRAS—pancreatic cancer	1.78e-05	0.000252	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.77e-05	0.00025	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.75e-05	0.000248	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.71e-05	0.000243	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.7e-05	0.000241	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CA—pancreatic cancer	1.64e-05	0.000232	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.58e-05	0.000224	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TP53—pancreatic cancer	1.58e-05	0.000224	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—TYMS—pancreatic cancer	1.57e-05	0.000222	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.56e-05	0.000221	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.55e-05	0.000219	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.52e-05	0.000216	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.52e-05	0.000216	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—HRAS—pancreatic cancer	1.51e-05	0.000214	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.51e-05	0.000214	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.51e-05	0.000214	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—DPYD—pancreatic cancer	1.49e-05	0.00021	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CD44—pancreatic cancer	1.48e-05	0.00021	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.45e-05	0.000205	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.45e-05	0.000205	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.43e-05	0.000202	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.42e-05	0.000202	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GCG—pancreatic cancer	1.42e-05	0.000201	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.41e-05	0.0002	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.41e-05	0.0002	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.4e-05	0.000198	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.39e-05	0.000197	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.38e-05	0.000195	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—AKT1—pancreatic cancer	1.34e-05	0.000189	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—STK11—pancreatic cancer	1.34e-05	0.000189	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.33e-05	0.000188	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.32e-05	0.000187	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	1.32e-05	0.000187	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.3e-05	0.000185	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.28e-05	0.000181	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—APOE—pancreatic cancer	1.27e-05	0.00018	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.26e-05	0.000178	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.26e-05	0.000178	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.15e-05	0.000164	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CG—pancreatic cancer	1.15e-05	0.000163	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—TYMS—pancreatic cancer	1.15e-05	0.000163	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.15e-05	0.000162	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CD44—pancreatic cancer	1.12e-05	0.000158	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PPARG—pancreatic cancer	1.11e-05	0.000157	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.1e-05	0.000155	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CD44—pancreatic cancer	1.09e-05	0.000155	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.09e-05	0.000154	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GCG—pancreatic cancer	1.07e-05	0.000152	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GCG—pancreatic cancer	1.05e-05	0.000148	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CD44—pancreatic cancer	1.03e-05	0.000146	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CD44—pancreatic cancer	1.02e-05	0.000144	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CD—pancreatic cancer	1.01e-05	0.000143	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—STK11—pancreatic cancer	1.01e-05	0.000143	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	9.99e-06	0.000141	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	9.9e-06	0.00014	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GCG—pancreatic cancer	9.87e-06	0.00014	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—STK11—pancreatic cancer	9.85e-06	0.000139	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GCG—pancreatic cancer	9.78e-06	0.000139	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.47e-06	0.000134	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—APOE—pancreatic cancer	9.34e-06	0.000132	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	9.31e-06	0.000132	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—STK11—pancreatic cancer	9.28e-06	0.000131	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—STK11—pancreatic cancer	9.2e-06	0.00013	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—DPYD—pancreatic cancer	9.16e-06	0.00013	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CB—pancreatic cancer	8.81e-06	0.000125	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTGS2—pancreatic cancer	8.73e-06	0.000124	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	8.69e-06	0.000123	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—TYMS—pancreatic cancer	8.68e-06	0.000123	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.64e-06	0.000122	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—TYMS—pancreatic cancer	8.47e-06	0.00012	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	8.43e-06	0.000119	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PPARG—pancreatic cancer	8.14e-06	0.000115	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—TYMS—pancreatic cancer	7.98e-06	0.000113	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TYMS—pancreatic cancer	7.91e-06	0.000112	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTEN—pancreatic cancer	7.61e-06	0.000108	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	7.41e-06	0.000105	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—APOE—pancreatic cancer	7.06e-06	9.99e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—APOE—pancreatic cancer	6.89e-06	9.75e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CD44—pancreatic cancer	6.73e-06	9.53e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.68e-06	9.46e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—APOE—pancreatic cancer	6.49e-06	9.19e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	6.46e-06	9.14e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GCG—pancreatic cancer	6.45e-06	9.14e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—APOE—pancreatic cancer	6.44e-06	9.11e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTGS2—pancreatic cancer	6.4e-06	9.06e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	6.37e-06	9.02e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	6.22e-06	8.8e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PPARG—pancreatic cancer	6.15e-06	8.7e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.09e-06	8.62e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—STK11—pancreatic cancer	6.07e-06	8.59e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PPARG—pancreatic cancer	6e-06	8.49e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	5.86e-06	8.29e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	5.81e-06	8.22e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PPARG—pancreatic cancer	5.65e-06	8.01e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PPARG—pancreatic cancer	5.61e-06	7.94e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	5.6e-06	7.93e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTEN—pancreatic cancer	5.58e-06	7.9e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	5.47e-06	7.74e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CA—pancreatic cancer	5.37e-06	7.6e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.22e-06	7.39e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	5.15e-06	7.29e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	5.11e-06	7.23e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	4.88e-06	6.91e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	4.84e-06	6.85e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	4.76e-06	6.74e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTGS2—pancreatic cancer	4.72e-06	6.68e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	4.49e-06	6.36e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	4.45e-06	6.3e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	4.45e-06	6.3e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	4.41e-06	6.24e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—AKT1—pancreatic cancer	4.39e-06	6.21e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—APOE—pancreatic cancer	4.24e-06	6.01e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTEN—pancreatic cancer	4.22e-06	5.97e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTEN—pancreatic cancer	4.12e-06	5.83e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	3.94e-06	5.57e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTEN—pancreatic cancer	3.88e-06	5.49e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTEN—pancreatic cancer	3.85e-06	5.44e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.83e-06	5.42e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.7e-06	5.23e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.37e-06	4.77e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—AKT1—pancreatic cancer	3.22e-06	4.55e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	2.98e-06	4.21e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.94e-06	4.16e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.91e-06	4.12e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	2.9e-06	4.11e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.74e-06	3.87e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	2.71e-06	3.84e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.54e-06	3.59e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—AKT1—pancreatic cancer	2.43e-06	3.44e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—AKT1—pancreatic cancer	2.37e-06	3.36e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.24e-06	3.16e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—AKT1—pancreatic cancer	2.22e-06	3.14e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.79e-06	2.53e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.46e-06	2.07e-05	CbGpPWpGaD
